The predominant CD44 splice variant in prostate cancer binds fibronectin, and calcitonin stimulates its expression. (Q40248309)
Jump to navigation
Jump to search
scientific article published on July 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | The predominant CD44 splice variant in prostate cancer binds fibronectin, and calcitonin stimulates its expression. |
scientific article published on July 2006 |
Statements
The predominant CD44 splice variant in prostate cancer binds fibronectin, and calcitonin stimulates its expression (English)
Kenneth A Iczkowski
A Levi Omara-Opyene